# Effect of Nicotine on Brain Reward Pathways

> **NCT02346539** · PHASE1 · COMPLETED · sponsor: **Mclean Hospital** · enrollment: 46 (actual)

## Conditions studied

- Depressive Disorder

## Interventions

- **DRUG:** Nicotine polacrilex

## Key facts

- **NCT ID:** NCT02346539
- **Lead sponsor:** Mclean Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2017-11
- **Final completion:** 2017-11
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2018-03-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02346539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02346539, "Effect of Nicotine on Brain Reward Pathways". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT02346539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*